A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...
A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...
Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...
Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...
An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...
An estimated 610,000 people in the US died from cancer last year. That’s almost the same amount of people who perished in the country’s four-year civil war. At least two million more people were ...
The global artificial intelligence in clinical trials market, valued at US$1.20 billion in 2023, is forecasted to grow at a ...
US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...
A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...
The days of a simple cure are long over. We’ve arrived in 2025 — an era where health and wellness are buzzwords, diagnosis ...